N1-(2-(4-(1-benzylpiperidin-4-ylamino)-7-methoxyquinazolin-2-ylamino)ethyl)-N7-hydroxyheptanediamide

ID: ALA4294122

Chembl Id: CHEMBL4294122

PubChem CID: 145993977

Max Phase: Preclinical

Molecular Formula: C30H41N7O4

Molecular Weight: 563.70

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1ccc2c(NC3CCN(Cc4ccccc4)CC3)nc(NCCNC(=O)CCCCCC(=O)NO)nc2c1

Standard InChI:  InChI=1S/C30H41N7O4/c1-41-24-12-13-25-26(20-24)34-30(32-17-16-31-27(38)10-6-3-7-11-28(39)36-40)35-29(25)33-23-14-18-37(19-15-23)21-22-8-4-2-5-9-22/h2,4-5,8-9,12-13,20,23,40H,3,6-7,10-11,14-19,21H2,1H3,(H,31,38)(H,36,39)(H2,32,33,34,35)

Standard InChI Key:  AWFJKIGLLSWFNV-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA4294122

    ---

Associated Targets(Human)

HDAC1 Tclin Histone deacetylase (6747 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
EHMT2 Tchem Histone-lysine N-methyltransferase, H3 lysine-9 specific 3 (93046 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Ehmt2 Histone-lysine N-methyltransferase EHMT2 (20 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 563.70Molecular Weight (Monoisotopic): 563.3220AlogP: 3.70#Rotatable Bonds: 15
Polar Surface Area: 140.74Molecular Species: NEUTRALHBA: 9HBD: 5
#RO5 Violations: 1HBA (Lipinski): 11HBD (Lipinski): 5#RO5 Violations (Lipinski): 2
CX Acidic pKa: 8.91CX Basic pKa: 8.50CX LogP: 2.09CX LogD: 1.12
Aromatic Rings: 3Heavy Atoms: 41QED Weighted: 0.11Np Likeness Score: -1.06

References

1. Kargbo RB..  (2018)  Histone Deacetylase Inhibitors as Treatment for Targeting Multiple Components in Cancer Therapy.,  (3): [PMID:29541353] [10.1021/acsmedchemlett.8b00068]
2. Rabal O, San José-Enériz E, Agirre X, Sánchez-Arias JA, de Miguel I, Ordoñez R, Garate L, Miranda E, Sáez E, Vilas-Zornoza A, Pineda-Lucena A, Estella A, Zhang F, Wu W, Xu M, Prosper F, Oyarzabal J..  (2021)  Design and Synthesis of Novel Epigenetic Inhibitors Targeting Histone Deacetylases, DNA Methyltransferase 1, and Lysine Methyltransferase G9a with In Vivo Efficacy in Multiple Myeloma.,  64  (6.0): [PMID:33661013] [10.1021/acs.jmedchem.0c02255]

Source